We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App





Laboratory Testing Platform for Vitamin D Assay Validated

By LabMedica International staff writers
Posted on 20 Jul 2012
Print article
AACC 2012: The quality of Vitamin D assays was demonstrated based on performance metrics.

With a simple blood test, the Architect 25-OH Vitamin D assay can measure the stable form of Vitamin D (also known as 25-hydroxyvitamin D), which is the body’s repository of Vitamin D.

The Architect 25-OH Vitamin D assay by Abbott (Abbott Park, IL, USA) is a chemiluminescent microparticle immunoassay (CMIA), for the quantitative determination of 25-hydroxyvitamin D (25-OH vitamin D) in human serum and plasma. The Architect 25-OH Vitamin D assay is to be used as an aid in the assessment of vitamin D sufficiency. It is recommended that each laboratory establish its own reference range. Results should be used in conjunction with other data such as symptoms, results of other tests, clinical impressions.

The Vitamin D assay contains method variations; therefore, it is important to apply standardized quality metrics to quality control so that clinicians are confident that they can rely on test results.

A quality-management methodology called Six Sigma was applied by Abbott to its Vitamin D assay to quantify and improve the performance of the lab process and increase the accuracy and reliability of test results.

Mr. Westgard, an expert on quality control and method validation, and an instructor at the Mayo School of Health Sciences, presented on the panel Vitamin D Testing on Wednesday, July 18, 2012, at the American Association for Clinical Chemistry (AACC) Annual Meeting in Los Angeles (CA, USA). He described how the performance of automated 25-OH vitamin D immunoassays was compared to Liquid Chromatography–Mass Spectrometry (LC-MS) techniques.

Sten Westgard, director of client services and technology, Westgard QC, Inc., commented, "Six Sigma provides an objective tool for assessment of laboratory processes, along with quality requirements and performance data. Based on benchmarking evaluation using Sigma metrics, the Abbott ARCHITECT system has demonstrated a range of performance from excellent to world class.

Related Links:
Abbott




Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Real-time PCR System
GentierX3 Series

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: A blood test could predict lung cancer risk more accurately and reduce the number of required scans (Photo courtesy of 123RF)

Blood Test Accurately Predicts Lung Cancer Risk and Reduces Need for Scans

Lung cancer is extremely hard to detect early due to the limitations of current screening technologies, which are costly, sometimes inaccurate, and less commonly endorsed by healthcare professionals compared... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: Microscope image showing human colorectal cancer tumor with Fusobacterium nucleatum stained in a red-purple color (Photo courtesy of Fred Hutch Cancer Center)

Mouth Bacteria Test Could Predict Colon Cancer Progression

Colon cancer, a relatively common but challenging disease to diagnose, requires confirmation through a colonoscopy or surgery. Recently, there has been a worrying increase in colon cancer rates among younger... Read more

Pathology

view channel
Image: The new method could reduce undiagnosed cancer cases in less-developed regions (Photo courtesy of 123RF)

New Method Offers Sustainable Approach to Universal Metabolic Cancer Diagnosis

Globally, more than one billion people suffer from a high rate of missed disease diagnosis, highlighting the urgent need for more precise and affordable diagnostic tools. Such tools are especially crucial... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.